DD201889A5 - Verfahren zur herstellung von neuen indolinonen - Google Patents

Verfahren zur herstellung von neuen indolinonen Download PDF

Info

Publication number
DD201889A5
DD201889A5 DD81234742A DD23474281A DD201889A5 DD 201889 A5 DD201889 A5 DD 201889A5 DD 81234742 A DD81234742 A DD 81234742A DD 23474281 A DD23474281 A DD 23474281A DD 201889 A5 DD201889 A5 DD 201889A5
Authority
DD
German Democratic Republic
Prior art keywords
indolinone
dimethyl
general formula
group
theory
Prior art date
Application number
DD81234742A
Other languages
German (de)
English (en)
Inventor
Erich Mueller
Josef Nickl
Josef Roch
Berthold Narr
Walter Haarmann
Johannes M Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DD201889A5 publication Critical patent/DD201889A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD81234742A 1980-11-12 1981-11-10 Verfahren zur herstellung von neuen indolinonen DD201889A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3042632 1980-11-12

Publications (1)

Publication Number Publication Date
DD201889A5 true DD201889A5 (de) 1983-08-17

Family

ID=6116579

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81234742A DD201889A5 (de) 1980-11-12 1981-11-10 Verfahren zur herstellung von neuen indolinonen

Country Status (29)

Country Link
US (1) US4629733A (xx)
JP (1) JPS57114569A (xx)
KR (1) KR880002227B1 (xx)
AT (1) AT375923B (xx)
AU (1) AU547929B2 (xx)
BE (1) BE891103A (xx)
CA (1) CA1183848A (xx)
CH (1) CH652120A5 (xx)
DD (1) DD201889A5 (xx)
DK (1) DK154138C (xx)
ES (2) ES507015A0 (xx)
FI (1) FI75806C (xx)
FR (1) FR2493841A1 (xx)
GB (1) GB2098595B (xx)
GR (1) GR81330B (xx)
HU (1) HU183680B (xx)
IE (1) IE52107B1 (xx)
IL (1) IL64252A (xx)
IT (1) IT1171624B (xx)
LU (1) LU83744A1 (xx)
NL (1) NL8105100A (xx)
NO (1) NO156167C (xx)
NZ (1) NZ198941A (xx)
PL (1) PL134525B1 (xx)
PT (1) PT73969B (xx)
SE (1) SE452156B (xx)
SU (1) SU1107759A3 (xx)
YU (1) YU41995B (xx)
ZA (1) ZA817787B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089394A1 (en) * 1982-03-23 1983-09-28 Sterling Drug Inc. 1-H-Indole-2,3-dione derivatives and preparation thereof
US5272145A (en) * 1989-08-22 1993-12-21 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
US5204344A (en) * 1989-08-22 1993-04-20 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
US5290798A (en) * 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5190968A (en) * 1991-09-30 1993-03-02 Merck Frosst Canada, Inc. (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis
US5389650A (en) * 1991-09-30 1995-02-14 Merck Frosst Canada, Inc. (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5308850A (en) * 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5374635A (en) * 1993-03-29 1994-12-20 Merck Frosst Canada, Inc. Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT330169B (de) * 1971-06-24 1976-06-25 Sandoz Ag Verfahren zur herstellung neuer oxindole und ihrer salze
US4329347A (en) * 1978-02-17 1982-05-11 Boehringer Ingelheim Gmbh Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril
DE2853314A1 (de) * 1978-12-09 1980-06-26 Thomae Gmbh Dr K Neue carbostyril- und oxindolderivate, ihre herstellung und ihre verwendung als arzneimittel
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2

Also Published As

Publication number Publication date
FR2493841B1 (xx) 1984-03-30
GR81330B (xx) 1984-12-11
GB2098595A (en) 1982-11-24
YU266681A (en) 1983-10-31
ES8206470A1 (es) 1982-08-16
NO813821L (no) 1982-05-13
LU83744A1 (de) 1983-04-13
SE452156B (sv) 1987-11-16
CA1183848A (en) 1985-03-12
AT375923B (de) 1984-09-25
IT1171624B (it) 1987-06-10
FI75806C (fi) 1988-08-08
PL233774A1 (xx) 1982-12-20
GB2098595B (en) 1984-09-05
NO156167B (no) 1987-04-27
CH652120A5 (de) 1985-10-31
YU41995B (en) 1988-04-30
AU7739081A (en) 1982-05-20
ES507015A0 (es) 1982-08-16
IT8149602A0 (it) 1981-10-30
FR2493841A1 (fr) 1982-05-14
IE812640L (en) 1982-05-12
AU547929B2 (en) 1985-11-14
FI813561L (fi) 1982-05-13
NO156167C (no) 1987-08-05
FI75806B (fi) 1988-04-29
IL64252A0 (en) 1982-02-28
ES8304081A1 (es) 1983-02-16
SU1107759A3 (ru) 1984-08-07
BE891103A (fr) 1982-05-12
DK496781A (da) 1982-05-13
JPS57114569A (en) 1982-07-16
HU183680B (en) 1984-05-28
KR830007554A (ko) 1983-10-21
ATA478981A (de) 1984-02-15
KR880002227B1 (ko) 1988-10-20
US4629733A (en) 1986-12-16
NZ198941A (en) 1984-10-19
PL134525B1 (en) 1985-08-31
IL64252A (en) 1985-02-28
PT73969B (de) 1983-11-23
DK154138C (da) 1989-04-17
NL8105100A (nl) 1982-06-01
DK154138B (da) 1988-10-17
IE52107B1 (en) 1987-06-24
ZA817787B (en) 1983-07-27
SE8106704L (sv) 1982-05-13
ES511834A0 (es) 1983-02-16
PT73969A (de) 1981-12-01

Similar Documents

Publication Publication Date Title
DE3152880C2 (xx)
EP0031954A2 (de) Neue Sulfonamide, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0331983A2 (de) Neue Stilbenderivate, ihre Herstellung und Verwendung für Heilmittel
DD201889A5 (de) Verfahren zur herstellung von neuen indolinonen
EP0111746B1 (de) Neue Sulfonsäureester von Hydroxycumarinen, ihre Herstellung und sie enthaltende Arzneimittel
EP0043788B1 (de) Neue Imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0239907A1 (de) Neue Phenoxyalkylcarbonsäure-Derivate, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
DE2602643C2 (de) 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
EP0095640A1 (de) Alkylenverbrückte Guanidinothiazolderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE3217012A1 (de) Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel
EP0093252A2 (de) Thiomethylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0071150B1 (de) Sulfimine, deren Salze und deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2546319C2 (de) Cyclohexylphenyl-Derivate, Verfahren zu deren Herstellung und diese enthaltende Mittel
EP0003771A1 (de) Neue Carbostyrilderivate, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3143327A1 (de) "neue indolinone, ihre herstellung und ihre verwendung als arzneimittel"
AT374185B (de) Verfahren zur herstellung von neuen carbostyril- und oxindolderivaten
AT374184B (de) Verfahren zur herstellung von neuen carbostyril- und oxindolderivaten
DE3426564A1 (de) Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind
DE2806721A1 (de) Neue carbostyril-derivate
US4058522A (en) Steroids effective against heavy-metal poisoning
KR830000852B1 (ko) 카보스티릴 및 옥스인돌 유도체의 제조방법
DD202871A5 (de) Verfahren zur herstellung von sulfiminen
DD247215A5 (de) Verfahren zur herstellung von neuen sulfonylaminoaethylverbindungen
DE3142904A1 (de) Arzneimittel zur vermeidung von tumormetasierung
DE1058517B (de) Verfahren zur Herstellung therapeutisch wertvoller 1, 2-Diphenyl-3, 5-dioxo-4-(benzthiazolylmercapto-alkyl)-pyrazolidine